Search

Your search keyword '"Solomon, Ben"' showing total 281 results

Search Constraints

Start Over You searched for: Author "Solomon, Ben" Remove constraint Author: "Solomon, Ben"
281 results on '"Solomon, Ben"'

Search Results

1. Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

2. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

3. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

4. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

5. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

6. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

7. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

9. De novo variants in DENND5B cause a neurodevelopmental disorder

10. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

12. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

13. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

14. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

15. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

16. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

17. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

18. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

19. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

22. De novo variants in DENND5B cause a neurodevelopmental disorder

23. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

24. Trends in primary care blood tests prior to lung and colorectal cancer diagnosis—A retrospective cohort study using linked Australian data.

25. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

26. First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)

27. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

28. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

29. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

30. FIGHTING THEIR WAY OUT OF POVERTY

32. T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

33. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

34. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

37. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

38. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

39. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

43. What Is Being Done to Educate for Leisure?

45. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

46. Neoadjuvant immunotherapy for non-small cell lung cancer : Right drugs, right patient, right time?

49. In need of help on kickoffs, Huskers evaluating transfer kicker options

50. The AP-1 transcription factor Batf controls [T.sub.H]17 differentiation

Catalog

Books, media, physical & digital resources